IL6 and acute myeloid leukemia: Furthermore, IL6 and ferritin are pro-inflammatory markers strongly associated with poor outcomes in patients with AML, and the anti-inflammatory molecule dexamethasone potentiates the effect of chemotherapies in patients with AML displaying a high white blood cell count26, demonstrating the urge to find new markers of inflammation to better adapt treatment of AML to the patient.